| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
86,163 |
73,598 |
$2.10M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28,400 |
27,800 |
$354K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14,742 |
14,377 |
$285K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,687 |
9,555 |
$228K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,070 |
6,957 |
$164K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,069 |
5,930 |
$158K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,213 |
3,140 |
$89K |
| 3008F |
|
21,861 |
21,286 |
$81K |
| 83655 |
|
6,566 |
6,414 |
$65K |
| 86580 |
|
22,223 |
22,169 |
$62K |
| 36415 |
Collection of venous blood by venipuncture |
33,601 |
29,477 |
$60K |
| 90670 |
|
1,293 |
1,240 |
$30K |
| 90473 |
|
1,952 |
1,950 |
$24K |
| 99381 |
|
719 |
709 |
$24K |
| 90656 |
|
6,314 |
6,306 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
821 |
761 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
293 |
293 |
$16K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
687 |
687 |
$15K |
| 36406 |
|
2,453 |
2,411 |
$14K |
| 90734 |
|
715 |
635 |
$10K |
| 90651 |
|
751 |
712 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
327 |
178 |
$7K |
| 90620 |
|
325 |
267 |
$6K |
| 97803 |
|
22,586 |
22,004 |
$5K |
| 90671 |
|
334 |
265 |
$5K |
| 90723 |
|
872 |
871 |
$5K |
| 99383 |
|
153 |
110 |
$3K |
| 90710 |
|
182 |
130 |
$3K |
| 99382 |
|
145 |
110 |
$2K |
| 92551 |
|
430 |
296 |
$2K |
| 90672 |
|
1,006 |
1,004 |
$1K |
| 90633 |
|
599 |
502 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
301 |
73 |
$992.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
279 |
123 |
$963.96 |
| 90648 |
|
817 |
771 |
$712.51 |
| 99177 |
|
691 |
515 |
$686.40 |
| 90655 |
|
697 |
693 |
$651.31 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
134 |
131 |
$636.36 |
| 90680 |
|
349 |
314 |
$600.88 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
101 |
99 |
$594.00 |
| 90696 |
|
136 |
78 |
$472.71 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
103 |
28 |
$438.57 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
178 |
177 |
$328.74 |
| 90715 |
|
134 |
134 |
$288.70 |
| 99174 |
|
113 |
113 |
$171.42 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
85 |
57 |
$153.36 |
| 36410 |
|
163 |
88 |
$134.94 |
| 90716 |
|
89 |
42 |
$129.98 |
| 99000 |
|
2,891 |
1,859 |
$91.52 |
| 99188 |
|
41 |
13 |
$70.00 |
| H0033 |
Oral medication administration, direct observation |
41 |
14 |
$40.00 |
| 99173 |
|
228 |
65 |
$10.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12 |
12 |
$4.00 |
| 90681 |
|
71 |
71 |
$1.03 |
| 90698 |
|
14 |
14 |
$0.00 |
| 90647 |
|
158 |
115 |
$0.00 |
| 99070 |
|
15 |
14 |
$0.00 |